Intravenous neridronate infusions, administered quarterly, significantly increase BMD and lower the risk of clinical fracture in prepubertal children with OI.
Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study.
GATTI, Davide;ANTONIAZZI, Franco;ROSSINI, Maurizio;Viapiana O.;ADAMI, Silvano
2005-01-01
Abstract
Intravenous neridronate infusions, administered quarterly, significantly increase BMD and lower the risk of clinical fracture in prepubertal children with OI.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2005 Gatti OI Bisphosphonates.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
89.7 kB
Formato
Adobe PDF
|
89.7 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
